HTG MOLECULAR DIAGNOSTICS IN (HTGMQ)
Institutional ownership reported to the SEC as of Q1 2023, across 5 quarters.
9
Reporting holders
$63.3K
Reported value
0.0%
Held as options
+2
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | $39.7K | 14,692 | 0.00% | new | NEW |
| UBS Group AG | $14.0K | 5,198 | 0.00% | 2q | +163.2%+$8.7K |
| BlackRock Inc. | $3.5K | 1,289 | 0.00% | 2q | -78.9%-$13.0K |
| MORGAN STANLEY | $2.4K | 884 | 0.00% | 2q | HELD |
| HighMark Wealth Management LLC | $1.6K | 580 | 0.00% | 2q | HELD |
| Nordwand Advisors, LLC | $1.4K | 500 | 0.00% | new | NEW |
| Allworth Financial LP | $754 | 279 | 0.00% | 2q | +0.7% |
| WELLS FARGO & COMPANY/MN | $35 | 13 | 0.00% | 2q | +225.0% |
| TCI Wealth Advisors, Inc. | $6 | 2 | 0.00% | 2q | HELD |
| Tower Research Capital LLC (TRC) | $4 | 1,481 | 0.00% | 2q | -77.9% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2023 | 9 | $63.3K | 23,437 | 2 | 3 | 1 | 0.0% |
| Q4 2022 | 7 | $39.2K | 9,826 | 7 | 0 | 0 | 0.0% |
| Q4 2020 | 1 | $18.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q3 2020 | 1 | $2.0K | 0 | 2 | 0 | 0 | 100.0% |
| Q4 2018 | 1 | $32.0K | 0 | 0 | 0 | 0 | 100.0% |